Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by telmanon Jun 20, 2023 11:28am
101 Views
Post# 35505280

RE:RE:RE:RE:RE:Temporary Repricing of Warrants Expiring in 2023 and 2024

RE:RE:RE:RE:RE:Temporary Repricing of Warrants Expiring in 2023 and 2024why not just extend the warrants like they have been doing?

The shareprice I guess might get back up to $0.065 a share for the exercise price.  How many warrants do you need to them buy one $0.065 share?  When that happens will they hold them or dump them?

I thought it was 8 for 1 when I bought them.  If thats the case I have 1,397,500 warrants so I need to come up with another $11,355 to try and save the $50K I am in the hole right now on just warrants.

Seems to me they are doing this to force the hand of the investors.  What facts have investors been given that anyone should put another dime into this company but now they force us to spend more or to finally accept the money we put into warrants is gone.

After this goes through I see the price tanking even further.  Why wouldnt it?


<< Previous
Bullboard Posts
Next >>